Stay updated on Durvalumab Combinations in Muscle Invasive Bladder Cancer Clinical Trial
Sign up to get notified when there's something new on the Durvalumab Combinations in Muscle Invasive Bladder Cancer Clinical Trial page.

Latest updates to the Durvalumab Combinations in Muscle Invasive Bladder Cancer Clinical Trial page
- Check3 days agoChange DetectedA new revision label v3.5.4 appears in the record history, replacing the previous v3.5.3. This reflects an internal update to the page rendering rather than any change to trial data or user-facing content.SummaryDifference0.1%

- Check10 days agoNo Change Detected
- Check18 days agoChange DetectedRevision: v3.5.3 replaces v3.5.2 on the page, indicating a new build of the ClinicalTrials.gov history view. This update is a metadata/version change and does not alter study data, records, or user-facing functionality.SummaryDifference0.1%

- Check25 days agoNo Change Detected
- Check32 days agoChange DetectedAdded Contacts/Locations and Study Status sections in the version history, updating the record with current recruitment status and location details. The revision is v3.5.2.SummaryDifference0.4%

- Check54 days agoChange DetectedAdded Revision: v3.5.0 to the history and removed Revision: v3.4.3.SummaryDifference0.1%

- Check68 days agoChange DetectedA new revision entry (v3.4.3) was added to the history, replacing the previous entry (v3.4.2).SummaryDifference0.1%

- Check96 days agoChange DetectedThe history shows a new site revision, v3.4.2, replacing the previous v3.4.1 notice about government funding and operating status. The old funding-status notice has been removed; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

Stay in the know with updates to Durvalumab Combinations in Muscle Invasive Bladder Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Durvalumab Combinations in Muscle Invasive Bladder Cancer Clinical Trial page.